Evidence map›Paper›PMID 32743038›Full record

ArticleGynecologic oncology reports2020

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix.

Hiroko Murata, Harumi Nakamura, Yukinobu Ohta, Masanori Kitamura, Shinichi Nakastuka, Jun Ishikawa, Shoji Kamiura

Erratum issuedOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hiroko MurataDepartment of Gynecologic Oncology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Harumi NakamuraDepartment of Pathology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Yukinobu OhtaDepartment of Gynecologic Oncology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Masanori KitamuraDepartment of Pathology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Shinichi NakastukaDepartment of Pathology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Jun IshikawaDepartment of Hematology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Shoji KamiuraDepartment of Gynecologic Oncology, Osaka International Cancer Institute, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 841-8567, Japan.
Osaka Medical Center for Cancer and Cardiovascular Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphoma with prominent spindle cell features is a morphological variant of diffuse large B-cell lymphoma (DLBCL) and is categorized as a rare variant by the WHO classification. Most cases arise from the skin, with only two cases reported in the uterine cervix to date. Here, we report two cases of spindle cell variant DLBCL of the uterine cervix. Although these cases might be rare, we believe that, as gynecologists and pathologists increase their knowledge of this variant type, more cases will be diagnosed properly.

Indexed as

Malignant lymphomaNeedle biopsyR-CHOP chemotherapySpindle cell variant DLBCLUterine cervix

Identifiers

PMID32743038
PMCPMC7388186
OpenAlexW3043793173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.